Literature DB >> 27463063

Juvenile striatal white matter is resistant to ischemia-induced damage.

Jared T Ahrendsen1,2,3, Himmat S Grewal4, Sean P Hickey1, Cecilia M Culp1, Elizabeth A Gould1,2, Takeru Shimizu4, Frank A Strnad4, Richard J Traystman2,5, Paco S Herson2,4, Wendy B Macklin6,7,8.   

Abstract

White matter injury following ischemic stroke is a major cause of functional disability. Injury to both myelinated axons and oligodendrocytes, the myelin producing cells in the central nervous system, occurs in experimental models of ischemic stroke. Age-related changes in white matter vulnerability to ischemia have been extensively studied and suggest that both the perinatal and the aged periods are times of increased white matter vulnerability. However, sensitivity of white matter following stroke in the juvenile brain has not been evaluated. Interestingly, the late pediatric period is an important developmental stage, as it is the time of maximal myelination. The current study demonstrates that neurons in late pediatric/juvenile striatum are vulnerable to ischemic damage, with neuronal injury being comparable in juvenile and adult mice following ischemia. By contrast, actively myelinating striatal oligodendrocytes in the juvenile brain are resistant to ischemia, whereas adult oligodendrocytes are quite sensitive. As a result, myelin sheaths are remarkably intact and axons survive well in the injured striatum of juvenile mice. In addition to relative resistance of juvenile white matter, other glial responses were very different in juvenile and adult mice following cerebral ischemia, including differences in astrogliosis, fibrosis, NG2-cell reactivity, and vascular integrity. Together, these responses lead to long-term preservation of brain parenchyma in juvenile mice, compared to severe tissue loss and scarring in adult mice. Overall, the current study suggests that equivalent ischemic insults may result in less functional deficit in children compared to adults and an environment more conducive to long-term recovery. GLIA 2016;64:1972-1986.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  astrocyte; gliosis; myelin; oligodendrocyte; stroke; vasculature

Mesh:

Substances:

Year:  2016        PMID: 27463063      PMCID: PMC5886370          DOI: 10.1002/glia.23036

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  62 in total

1.  NG2 proteoglycan expression by pericytes in pathological microvasculature.

Authors:  Ugur Ozerdem; Edward Monosov; William B Stallcup
Journal:  Microvasc Res       Date:  2002-01       Impact factor: 3.514

Review 2.  Roles of NG2 glial cells in diseases of the central nervous system.

Authors:  Jian-Ping Xu; Jie Zhao; Shao Li
Journal:  Neurosci Bull       Date:  2011-12       Impact factor: 5.203

3.  Proteolipid promoter activity distinguishes two populations of NG2-positive cells throughout neonatal cortical development.

Authors:  Barbara S Mallon; H Elizabeth Shick; Grahame J Kidd; Wendy B Macklin
Journal:  J Neurosci       Date:  2002-02-01       Impact factor: 6.167

4.  Cognitive functioning, behavior, and quality of life after stroke in childhood.

Authors:  Regula Everts; Julia Pavlovic; Franz Kaufmann; Birgit Uhlenberg; Ulrich Seidel; Krassen Nedeltchev; Walter Perrig; Maja Steinlin
Journal:  Child Neuropsychol       Date:  2008-07       Impact factor: 2.500

5.  Cognitive outcome following unilateral arterial ischaemic stroke in childhood: effects of age at stroke and lesion location.

Authors:  Robyn Westmacott; Rand Askalan; Daune MacGregor; Peter Anderson; Gabrielle Deveber
Journal:  Dev Med Child Neurol       Date:  2009-08-20       Impact factor: 5.449

6.  Experimental pediatric arterial ischemic stroke model reveals sex-specific estrogen signaling.

Authors:  Paco S Herson; Chris G Bombardier; Susan M Parker; Takeru Shimizu; Jost Klawitter; Jelena Klawitter; Nidia Quillinan; Jennifer L Exo; Neil A Goldenberg; Richard J Traystman
Journal:  Stroke       Date:  2013-01-24       Impact factor: 7.914

7.  Neuropsychological problems after paediatric stroke: two year follow-up of Swiss children.

Authors:  J Pavlovic; F Kaufmann; E Boltshauser; A Capone Mori; D Gubser Mercati; C-A Haenggeli; E Keller; J Lütschg; J-P Marcoz; G-P Ramelli; E Roulet Perez; T Schmitt-Mechelke; M Weissert; M Steinlin
Journal:  Neuropediatrics       Date:  2006-02       Impact factor: 1.947

Review 8.  Management of stroke in infants and children: a scientific statement from a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young.

Authors:  E Steve Roach; Meredith R Golomb; Robert Adams; Jose Biller; Stephen Daniels; Gabrielle Deveber; Donna Ferriero; Blaise V Jones; Fenella J Kirkham; R Michael Scott; Edward R Smith
Journal:  Stroke       Date:  2008-07-17       Impact factor: 7.914

Review 9.  Oligodendrocyte pathophysiology and treatment strategies in cerebral ischemia.

Authors:  Gabriella Mifsud; Christian Zammit; Richard Muscat; Giuseppe Di Giovanni; Mario Valentino
Journal:  CNS Neurosci Ther       Date:  2014-04-07       Impact factor: 5.243

10.  Role of angiogenesis in patients with cerebral ischemic stroke.

Authors:  J Krupinski; J Kaluza; P Kumar; S Kumar; J M Wang
Journal:  Stroke       Date:  1994-09       Impact factor: 7.914

View more
  12 in total

Review 1.  Roles of NG2-glia in ischemic stroke.

Authors:  Fei-Er Song; Jia-Lv Huang; Si-Han Lin; Shuo Wang; Guo-Fen Ma; Xiao-Ping Tong
Journal:  CNS Neurosci Ther       Date:  2017-03-19       Impact factor: 5.243

Review 2.  Cerebral ischemia in the developing brain.

Authors:  Robert M Dietz; Andra L Dingman; Paco S Herson
Journal:  J Cereb Blood Flow Metab       Date:  2022-06-29       Impact factor: 6.960

3.  Endogenous Neuronal Replacement in the Juvenile Brain Following Cerebral Ischemia.

Authors:  Krista M Rodgers; Jared T Ahrendsen; Olivia P Patsos; Frank A Strnad; Joan C Yonchek; Richard J Traystman; Wendy B Macklin; Paco S Herson
Journal:  Neuroscience       Date:  2018-04-09       Impact factor: 3.590

Review 4.  The roles of neuron-NG2 glia synapses in promoting oligodendrocyte development and remyelination.

Authors:  Rongrong Li; Pu Zhang; Mao Zhang; Zhongxiang Yao
Journal:  Cell Tissue Res       Date:  2020-03-31       Impact factor: 5.249

5.  Experimental pediatric stroke shows age-specific recovery of cognition and role of hippocampal Nogo-A receptor signaling.

Authors:  James E Orfila; Robert M Dietz; Krista M Rodgers; Andra Dingman; Olivia P Patsos; Ivelisse Cruz-Torres; Himmat Grewal; Frank Strnad; Christian Schroeder; Paco S Herson
Journal:  J Cereb Blood Flow Metab       Date:  2019-02-14       Impact factor: 6.200

Review 6.  Microglia-leucocyte axis in cerebral ischaemia and inflammation in the developing brain.

Authors:  Aditya Rayasam; Yumi Fukuzaki; Zinaida S Vexler
Journal:  Acta Physiol (Oxf)       Date:  2021-05-30       Impact factor: 7.523

Review 7.  The Notch Signaling Pathway Regulates Differentiation of NG2 Cells into Oligodendrocytes in Demyelinating Diseases.

Authors:  Chengcai Li; Zhiping Xie; Zelong Xing; Huaxin Zhu; Wu Zhou; Shenke Xie; Zhixiong Zhang; Mei-Hua Li
Journal:  Cell Mol Neurobiol       Date:  2021-04-07       Impact factor: 4.231

Review 8.  Embracing oligodendrocyte diversity in the context of perinatal injury.

Authors:  Jessie Newville; Lauren L Jantzie; Lee Anna Cunningham
Journal:  Neural Regen Res       Date:  2017-10       Impact factor: 5.135

9.  Ischemia-Triggered Glutamate Excitotoxicity From the Perspective of Glial Cells.

Authors:  Denisa Belov Kirdajova; Jan Kriska; Jana Tureckova; Miroslava Anderova
Journal:  Front Cell Neurosci       Date:  2020-03-19       Impact factor: 5.505

Review 10.  Glial Cells as Therapeutic Approaches in Brain Ischemia-Reperfusion Injury.

Authors:  Ivó H Hernández; Mario Villa-González; Gerardo Martín; Manuel Soto; María José Pérez-Álvarez
Journal:  Cells       Date:  2021-06-30       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.